Early Diagnostic Markers for Contrast Nephropathy in Patients Undergoing Coronary Angiography

Angiology

Volumn 61, Issue 8, 2010, Pages 731-736

  Shaker, Olfat ^a   el Shehaby, Amal ^a   el Khatib, Mohamed ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

coronary angiography; cystatin C; NGAL; renal failure

Indexed keywords

ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; CONTRAST MEDIUM; CREATININE; CYSTATIN C; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ANGIOCARDIOGRAPHY; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; HUMAN; KIDNEY DISEASE; MIDDLE AGED;

ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATININE; CYSTATIN C; HUMANS; KIDNEY DISEASES; LIPOCALINS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS;

EID: 78049422189     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319710373093     Document Type: Article

References (31)

1. Huber W., Eckel F., Hennig M. Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study. Radiology. 2006; 239: 793-804.
2. Detrenis S., Meschi M., Musini S., Savazzi G. Lights and shadows on the pathogenesis of contrast-induced nephropathy: state of the art. Nephrol Dial Transplant. 2005; 20(8):1542-1550.
3. McCullough P. Outcomes of contrast- induced nephropathy: experience in patients undergoing cardiovascular intervention. Catheter Cardiovasc Interv. 2006; 67(3):335-343.
4. Bellomo R., Kellum JA, Ronco C. Defining acute renal failure: physiological principles. Intensive Care Med. 2004; 30(1):33-37.
5. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol. 2006; 17(6):1503-1520.
6. Hirschberg R., Kopple J., Lipsett P., et al. Multicenter clinical trial of recombinant human insulin-like growth factor 1 in patients with acute renal failure. Kidney Int. 1999; 55(6):2423-2432.
7. Mishra J., Ma Q., Prada A., Zahedi K., Yang Y., Barasch J., Devarajan P. Identification of neutrophil gelatinase-associated lipocalin as a novel urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003; 14(10):2534-2543.
8. Mishra J., Mori K., Ma Q., Kelly C., Barasch J., Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL): a novel urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol. 2004; 24(3): 307-315.
9. Mori K., Lee HT, Rapoport D., et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest. 2005; 115(3):610-621.
10. Mishra J., Ma Q., Kelly C., Mitsnefes M., Devarajan P. Kidney NGAL is a novel early marker of acute renal injury following transplantation. Pediatr Nephrol. 2006; 21(6):856-863.
11. Dharnidharka VR, Kwon C., Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002; 40(2):221-226.
12. Herget-Rosenthal S., Marggraf G., Hüsing J., et al. Early detection of acute renal failure by serum cystatin C. Kidney Int. 2004; 66(3): 1115-1122.
13. VandeVoorde RG, Katlman TI, Ma Q., et al. Serum NGAL and cystatin C as predictive biomarkers for acute kidney injury. J Am Soc Nephrol. 2006; 17: 404A.
14. World Health Organization. Obesity: preventing and managing the global epidemic. Geneva, 1998.
15. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2005; 28(suppl 1):S37-S42.
16. Chobanian A. JNC VII report. Eighteenth Annual Scientific Meeting and Exposition of the American Society of Hypertension. New York. 2003; 14-17.
17. Dharnidharka VR, Kwon C., Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kid Dis. 2002; 40(2):221-226.
18. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT Hospital acquired renal insufficiency: a prospective study. Am J Med. 1983; 74(2):243-248.
19. Mishra J., Dent C., Tarabishi R., et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005; 365(9466):1231-1238.
20. Parikh CR, Jani A., Mishra J., et al. Urine NGAL and IL-18 are predictive biomarkers for DGF following kidney transplantation. Am J Transplant. 2006;6(7):1639-1645.
21. Mitsnefes M., Kathman T., Mishra J., et al. Serum NGAL as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol. 2007; 22(1):101-108.
22. Bachorzewska-Gajewska H., Malyszko J., Sitniewska E., Malyszko JS, Dobrzycki S. Neutrophil gelatinase-associated lipocalin and renal function after percutaneous coronary angiography. Am J Nephrol. 2006; 26(3):287-292.
23. Bachorzewska-Gajewska H., Malyszko J., Sitniewska E., Malyszko JS, Dobrzycki S. Neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine and eGFR in patients with normal serum creatinine undergoing coronary angiography. Nephrol Dial Transplant. 2007; 22(1): 295-296.
24. Wagener G., Jan M., Kim M., et al. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology. 2006; 105(3):485-491.
25. Hemdahl AL, Gabrielsen A., Zhu C. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Thromb Vasc Biol. 2006; 26(1):136-142.
26. Devarajan P., Mishra J., Supavekin S., Patterson LT, Potter SS. Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery and novel therapeutics. Mol Genet Metab. 2003; 80(4):365-376.
27. Mishra J., Mori K., Ma Q. Amelioration of ischemic acute renal injury by NGAL. J Am Soc Nephrol. 2004; 15(12):3073-3082.
28. Devarajan P. Novel biomarkers for the early predication of acute kidney injury. Cancer Ther. 2005; 3: 477-488.
29. Filler G., Lepage N. Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? Pediatr Nephrol. 2003; 18(10):981-985.
30. Rickli H., Benou K., Ammann P. Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media. Clin Nephrol. 2004; 61(2):98-102.
31. Gami AS, Garovic VD Contrast nephropathy after coronary angiography. Mayo Clin Proc. 2004; 79(2):211-219.